Mechanistic studies on the absorption enhancement of a self-nanoemulsifying drug delivery system loaded with norisoboldine-phospholipid complex
Jing Zhang,1,* Xiaoxia Wen,1,* Yue Dai,2 Yufeng Xia11Department of Pharmacognosy, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, People’s Republic of China; 2Department of Traditional Chinese Medicine and Pharmacology, School of Traditional Chinese...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/780ebd04b8864104b8a04009bb55023e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:780ebd04b8864104b8a04009bb55023e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:780ebd04b8864104b8a04009bb55023e2021-12-02T09:22:51ZMechanistic studies on the absorption enhancement of a self-nanoemulsifying drug delivery system loaded with norisoboldine-phospholipid complex1178-2013https://doaj.org/article/780ebd04b8864104b8a04009bb55023e2019-09-01T00:00:00Zhttps://www.dovepress.com/mechanistic-studies-on-the-absorption-enhancement-of-a-self-nanoemulsi-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Jing Zhang,1,* Xiaoxia Wen,1,* Yue Dai,2 Yufeng Xia11Department of Pharmacognosy, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, People’s Republic of China; 2Department of Traditional Chinese Medicine and Pharmacology, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, People’s Republic of China *These authors contributed equally to this workCorrespondence: Yufeng XiaDepartment of Pharmacognosy, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 639 Longmian Avenue, Jiangning District, Nanjing 211198, ChinaTel +86 25 83271400Fax +86 25 85301528Email yfxiacpu@126.comYue DaiDepartment of Traditional Chinese Medicine and Pharmacology, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 639 Longmian Avenue, Nanjing 211198, ChinaEmail yuedaicpu@126.comBackground: Norisoboldine (NOR), the main isoquinoline alkaloid constituent in Radix Linderae, was demonstrated to have an outstanding anti-arthritis activity. However, a poor oral bioavailability of NOR creates a barrier for its development and application.Methods: A new self-nanoemulsifying drug delivery system (SNEDDS) loaded with the phospholipid complex (PC) was designed to improve the oral bioavailability of NOR. NOR-PC was prepared by solvent evaporation method with a mixture of phospholipid and NOR at a mass ratio of 3:1. The property of PC is to improve the liposolubility of NOR, and made PC embedded in the drug delivery system. The physicochemical property of NOR-PC was characterized by differential scanning calorimetry (DSC) and Fourier transform infrared spectroscopy (FT-IR). According to the ability to dissolve NOR-PC, the oil and cosurfactant were chosen. The surfactant was selected based on its emulsification efficiency in SNEDDS. Pseudo-ternary phase diagram was created to select the best formulation of NOR-PC-SNEDDS, and the pharmacokinetic parameters were detected in rats. In addition, intestinal lymphatic transport and liver microsome experiment were studied to gain insight into the mechanism for NOR-PC-SNEDDS increasing the oral bioavailability of NOR.Results: Solubility detection showed that the PC significantly improved the liposolubility of NOR. NOR-PC-SNEDDS was prepared using NOR-PC, Ethyl oleate, Labrasol, Cremophor EL and transcutol HP at a weight ratio of 1:2:3.36:2.24:2.4 (w/w/w/w/w). The particle size and zeta potential of NOR-PC-SNEDDS were 36.72±1.47 nm and −4.91±0.49 mV after dilution with distilled water at a ratio of 1:50 (w/w). The absolute bioavailability of NOR in the NOR-PC-SNEDDS group significantly increased and the value was 372% in relative to NOR group. Further studies indicated that NOR-PC-SNEDDS promoted the oral bioavailability of NOR by enhancing intestinal lymphatic absorption and inhibiting Phase II metabolism of NOR.Conclusion: These findings suggested that NOR-PC-SNEDDS was able to promote the oral bioavailability of NOR, which provided a foundation for the further development and application of NOR.Keywords: norisoboldine, oral bioavailability, self-nanoemulsifying drug delivery system, lymphatic absorption, Phase II metabolismZhang JWen XDai YXia YDove Medical Pressarticlenorisoboldineoral bioavailabilityself-nanoemulsifying drug delivery systemlymphatic absorptionII-phase metabolismMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 7095-7106 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
norisoboldine oral bioavailability self-nanoemulsifying drug delivery system lymphatic absorption II-phase metabolism Medicine (General) R5-920 |
spellingShingle |
norisoboldine oral bioavailability self-nanoemulsifying drug delivery system lymphatic absorption II-phase metabolism Medicine (General) R5-920 Zhang J Wen X Dai Y Xia Y Mechanistic studies on the absorption enhancement of a self-nanoemulsifying drug delivery system loaded with norisoboldine-phospholipid complex |
description |
Jing Zhang,1,* Xiaoxia Wen,1,* Yue Dai,2 Yufeng Xia11Department of Pharmacognosy, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, People’s Republic of China; 2Department of Traditional Chinese Medicine and Pharmacology, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, People’s Republic of China *These authors contributed equally to this workCorrespondence: Yufeng XiaDepartment of Pharmacognosy, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 639 Longmian Avenue, Jiangning District, Nanjing 211198, ChinaTel +86 25 83271400Fax +86 25 85301528Email yfxiacpu@126.comYue DaiDepartment of Traditional Chinese Medicine and Pharmacology, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 639 Longmian Avenue, Nanjing 211198, ChinaEmail yuedaicpu@126.comBackground: Norisoboldine (NOR), the main isoquinoline alkaloid constituent in Radix Linderae, was demonstrated to have an outstanding anti-arthritis activity. However, a poor oral bioavailability of NOR creates a barrier for its development and application.Methods: A new self-nanoemulsifying drug delivery system (SNEDDS) loaded with the phospholipid complex (PC) was designed to improve the oral bioavailability of NOR. NOR-PC was prepared by solvent evaporation method with a mixture of phospholipid and NOR at a mass ratio of 3:1. The property of PC is to improve the liposolubility of NOR, and made PC embedded in the drug delivery system. The physicochemical property of NOR-PC was characterized by differential scanning calorimetry (DSC) and Fourier transform infrared spectroscopy (FT-IR). According to the ability to dissolve NOR-PC, the oil and cosurfactant were chosen. The surfactant was selected based on its emulsification efficiency in SNEDDS. Pseudo-ternary phase diagram was created to select the best formulation of NOR-PC-SNEDDS, and the pharmacokinetic parameters were detected in rats. In addition, intestinal lymphatic transport and liver microsome experiment were studied to gain insight into the mechanism for NOR-PC-SNEDDS increasing the oral bioavailability of NOR.Results: Solubility detection showed that the PC significantly improved the liposolubility of NOR. NOR-PC-SNEDDS was prepared using NOR-PC, Ethyl oleate, Labrasol, Cremophor EL and transcutol HP at a weight ratio of 1:2:3.36:2.24:2.4 (w/w/w/w/w). The particle size and zeta potential of NOR-PC-SNEDDS were 36.72±1.47 nm and −4.91±0.49 mV after dilution with distilled water at a ratio of 1:50 (w/w). The absolute bioavailability of NOR in the NOR-PC-SNEDDS group significantly increased and the value was 372% in relative to NOR group. Further studies indicated that NOR-PC-SNEDDS promoted the oral bioavailability of NOR by enhancing intestinal lymphatic absorption and inhibiting Phase II metabolism of NOR.Conclusion: These findings suggested that NOR-PC-SNEDDS was able to promote the oral bioavailability of NOR, which provided a foundation for the further development and application of NOR.Keywords: norisoboldine, oral bioavailability, self-nanoemulsifying drug delivery system, lymphatic absorption, Phase II metabolism |
format |
article |
author |
Zhang J Wen X Dai Y Xia Y |
author_facet |
Zhang J Wen X Dai Y Xia Y |
author_sort |
Zhang J |
title |
Mechanistic studies on the absorption enhancement of a self-nanoemulsifying drug delivery system loaded with norisoboldine-phospholipid complex |
title_short |
Mechanistic studies on the absorption enhancement of a self-nanoemulsifying drug delivery system loaded with norisoboldine-phospholipid complex |
title_full |
Mechanistic studies on the absorption enhancement of a self-nanoemulsifying drug delivery system loaded with norisoboldine-phospholipid complex |
title_fullStr |
Mechanistic studies on the absorption enhancement of a self-nanoemulsifying drug delivery system loaded with norisoboldine-phospholipid complex |
title_full_unstemmed |
Mechanistic studies on the absorption enhancement of a self-nanoemulsifying drug delivery system loaded with norisoboldine-phospholipid complex |
title_sort |
mechanistic studies on the absorption enhancement of a self-nanoemulsifying drug delivery system loaded with norisoboldine-phospholipid complex |
publisher |
Dove Medical Press |
publishDate |
2019 |
url |
https://doaj.org/article/780ebd04b8864104b8a04009bb55023e |
work_keys_str_mv |
AT zhangj mechanisticstudiesontheabsorptionenhancementofaselfnanoemulsifyingdrugdeliverysystemloadedwithnorisoboldinephospholipidcomplex AT wenx mechanisticstudiesontheabsorptionenhancementofaselfnanoemulsifyingdrugdeliverysystemloadedwithnorisoboldinephospholipidcomplex AT daiy mechanisticstudiesontheabsorptionenhancementofaselfnanoemulsifyingdrugdeliverysystemloadedwithnorisoboldinephospholipidcomplex AT xiay mechanisticstudiesontheabsorptionenhancementofaselfnanoemulsifyingdrugdeliverysystemloadedwithnorisoboldinephospholipidcomplex |
_version_ |
1718398129654464512 |